On Friday, Zevra Therapeutics Inc (NASDAQ: ZVRA) opened lower -3.79% from the last session, before settling in for the closing price of $9.23. Price fluctuations for ZVRA have ranged from $6.19 to $13.16 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 29.64% over the past five years. Company’s average yearly earnings per share was noted 154.82% at the time writing. With a float of $55.84 million, this company’s outstanding shares have now reached $56.22 million.
Zevra Therapeutics Inc (ZVRA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Zevra Therapeutics Inc is 0.81%, while institutional ownership is 71.06%. The most recent insider transaction that took place on Oct 10 ’25, was worth 210,908. In this transaction President and CEO of this company sold 19,500 shares at a rate of $10.82, taking the stock ownership to the 222,016 shares. Before that another transaction happened on Oct 10 ’25, when Company’s Director proposed sale 19,500 for $10.82, making the entire transaction worth $210,990.
Zevra Therapeutics Inc (ZVRA) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.69 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.4) by -0.29. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.09 per share during the current fiscal year.
Zevra Therapeutics Inc (NASDAQ: ZVRA) Trading Performance Indicators
Check out the current performance indicators for Zevra Therapeutics Inc (ZVRA). In the past quarter, the stock posted a quick ratio of 8.57. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.63, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.56 in one year’s time.
Technical Analysis of Zevra Therapeutics Inc (ZVRA)
Zevra Therapeutics Inc (NASDAQ: ZVRA) saw its 5-day average volume 1.57 million, a positive change from its year-to-date volume of 1.06 million. As of the previous 9 days, the stock’s Stochastic %D was 32.20%.
During the past 100 days, Zevra Therapeutics Inc’s (ZVRA) raw stochastic average was set at 28.67%, which indicates a significant increase from 13.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.59 in the past 14 days, which was higher than the 0.56 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.58, while its 200-day Moving Average is $9.02. Nevertheless, the first resistance level for the watch stands at $9.24 in the near term. At $9.59, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.78. If the price goes on to break the first support level at $8.70, it is likely to go to the next support level at $8.51. The third support level lies at $8.16 if the price breaches the second support level.
Zevra Therapeutics Inc (NASDAQ: ZVRA) Key Stats
There are currently 56,298K shares outstanding in the company with a market cap of 499.92 million. Presently, the company’s annual sales total 23,610 K according to its annual income of -105,510 K. Last quarter, the company’s sales amounted to 26,060 K and its income totaled -540 K.
